Rankings
▼
Calendar
ORGO FY 2023 Earnings — Organogenesis Holdings Inc. Revenue & Financial Results | Market Cap Arena
ORGO
Organogenesis Holdings Inc.
$355M
FY 2023 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$433M
-3.9% YoY
Gross Profit
$327M
75.4% margin
Operating Income
$13M
2.9% margin
Net Income
$5M
1.1% margin
EPS (Diluted)
$0.04
Cash Flow
Operating Cash Flow
$31M
Free Cash Flow
$7M
Stock-Based Comp.
$9M
Balance Sheet
Total Assets
$460M
Total Liabilities
$181M
Stockholders' Equity
$279M
Cash & Equivalents
$104M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$433M
$451M
-3.9%
Gross Profit
$327M
$346M
-5.6%
Operating Income
$13M
$22M
-43.8%
Net Income
$5M
$16M
-68.2%
← Q4 2022
All Quarters
Q1 2023 →